Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Isradipine

A dihydropyridine calcium channel blocker that relaxes the arteries and lowers blood pressure: patented in 1978 and approved for medical use in 1989 against hypertension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Instead of the classic phenyl ring of many dihydropyridines it carries a benzoxadiazole ring; in 2007 a study in mice pointed to it as a possible protector of nerve cells in Parkinson's disease.

IsradipineGo to the active ingredient →
IsradipineActive ingredientIsradipineCat. No. P-I102-001CAS 75695-93-1
Isradipine d3Isotopically labelledIsradipine d3Cat. No. P-I102-009CAS 1189959-59-8
Isradipine-d6Isotopically labelledIsradipine-d6Cat. No. P-I102-010CAS 1261398-97-3

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceIsradipine CRSEDQM code Y0000366Family Isradipine

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.